Skip to main content
Equibles

MetLife Investment Management, LLC

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1529735 Whippany, NJ
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$293,518
+$17,784 QoQ
Shares Held
36,644
+6.7% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 209 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. SPRY ranks #164 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in SPRY

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $293,518 36,644
2026-03-31 $275,734 34,338
2025-12-31 $400,037 34,338
2025-09-30 $345,096 34,338
2025-06-30 $571,958 32,777
2025-03-31 $408,032 32,435
2024-12-31 $349,057 33,086
2024-09-30 $425,096 29,317
2024-06-30 $249,487 29,317
2024-03-31 $140,872 13,784
2023-12-31 $75,536 13,784
2023-09-30 $52,103 13,784
2023-06-30 $92,352 13,784
2021-09-30 $90,798 9,098
2021-06-30 $170,729 5,527
2021-03-31 $241,143 5,527